Abstract
Resveratrol,
a polyphenolic compound, is a powerful antioxidant with remarkable
anti-inflammatory properties. Inflammation and pain plays an important role in
the pathogenesis of knee osteoarthritis (OA) and could cause tissue damage and
morbidity. The aim of this study was to evaluate the anti-inflammatory and pain
reduction activities of orally administered resveratrol in patients with knee
OA. We carried out a 90-day pilot study to evaluate the ability of orally administered
resveratrol, as an adjuvant with meloxicam, to decrease knee joint pain and
biomarkers of inflammation in comparison with a placebo. One hundred ten men
and women (45-75 years old) diagnosed with mild to moderate knee OA were
treated with 15 mg per day meloxicam and either 500 mg per day resveratrol or
placebo for 90 days in a double-blind, randomized control trial. Pain severity
was evaluated at the beginning and at the end of treatment using Visual
Analogue Scale-100 scores. Fasting blood was collected to determine serum
interleukins 1β and 6, tumor necrosis factor-α, C-reactive protein, and
complement proteins C3 and C4. The resveratrol-treated group experienced a
time-dependent significant decrease in pain severity (P < .001). Serum levels
of the biochemical markers were significantly reduced compared with the
placebo-treated group (P < .01). These findings suggest that resveratrol may
be an effective "add-on" option with meloxicam in the treatment of
patients with mild to moderate knee OA.
Keywords: inflammatory markers; knee OA; knee pain; meloxicam;
resveratrol.
Similar articles
Hussain SA, Marouf BH, Ali ZS, Ahmmad RS.Clin Interv Aging.
2018 Sep 5;13:1621-1630. doi: 10.2147/CIA.S172758. eCollection
2018.PMID: 30233159 Free PMC article. Clinical Trial.
Dehghani S, Alipoor E, Salimzadeh A, Yaseri M, Hosseini M,
Feinle-Bisset C, Hosseinzadeh-Attar MJ.Phytomedicine. 2018 Sep 15;48:70-75. doi:
10.1016/j.phymed.2018.04.060. Epub 2018 May 9.PMID: 30195882 Clinical
Trial.
Hussain SA, Jassim NA, Numan IT, Al-Khalifa II, Abdullah TA.Saudi Med J. 2009
Jan;30(1):98-103.PMID: 19139781 Clinical Trial.
Malek Mahdavi A, Mahdavi R, Kolahi S.J Am Coll Nutr. 2016
Sep-Oct;35(7):597-603. doi: 10.1080/07315724.2015.1068139. Epub 2016 Mar
2.PMID: 26933897 Clinical Trial.
Arjmandi BH, Ormsbee
LT, Elam ML, Campbell SC, Rahnama N, Payton ME, Brummel-Smith K, Daggy BP.J Med Food. 2014
Jun;17(6):707-13. doi: 10.1089/jmf.2013.0010. Epub 2014 Mar
10.PMID: 24611484 Free PMC article. Clinical Trial.
See all similar articles
Cited by 5 articles
Hodgin KS, Donovan EK, Kekes-Szabo S, Lin JC, Feick J, Massey
RL, Ness TJ, Younger JW.Int J Environ Res Public Health. 2021 Mar 3;18(5):2483. doi:
10.3390/ijerph18052483.PMID: 33802381 Free PMC article. Clinical Trial.
Sun S, Yan Z, Shui X, Qi W, Chen Y, Xu X, Hu Y, Guo W, Shang P.J Cell Mol Med. 2020
Nov;24(22):13104-13114. doi: 10.1111/jcmm.15915. Epub 2020 Oct
16.PMID: 33063931 Free PMC article.
Li XZ, Zhang SN.Chin Med. 2020 Aug 1;15:80. doi: 10.1186/s13020-020-00363-5.
eCollection 2020.PMID: 32765641 Free PMC article. Review.
D'Adamo S, Cetrullo S, Panichi V, Mariani E, Flamigni F, Borzì
RM.Cells.
2020 May 16;9(5):1232. doi: 10.3390/cells9051232.PMID: 32429348 Free PMC article. Review.
Deng Z, Li Y, Liu H,
Xiao S, Li L, Tian J, Cheng C, Zhang G, Zhang F.Biosci Rep. 2019 May
10;39(5):BSR20190189. doi: 10.1042/BSR20190189. Print 2019 May
31.PMID: 30996115 Free PMC article. Review.
Related information
LinkOut - more resources
- Full Text Sources
o Atypon
- Other Literature Sources
- Miscellaneous